http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007083323-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4696c290989e178010aa1908bcbb526d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ab776b9caf951211029e64e07c6068a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aaa8cf08e998b3ddf7927d943228bac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b735f147a8c094f1c87c78a18cd69428
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2007-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8f35183590e3159ba580bca59a5ae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_359131fb4e32ff02780352524a94244a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d06a485da124ea91220ec7e870e4e41
publicationDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007083323-A3
titleOfInvention Modified release oral dosage form comprising desmopressin
abstract The invention describes a modified release oral dosage form of desmopressin which upon administration releases two or more amounts of desmopressin. The dosage form comprises of individual dosage units, such as an immediate release dosage unit and one or more delayed release dosage units, each comprising of a suitable amount of desmopressin, released after a predetermined time interval. The dosage form of the invention provides a release profile, adapted such that the dosage form exhibits improved efficacy for a prolonged duration of action and provides for an overall superior management of antidiuretic therapy. The invention also provides for method of manufacture of the dosage form of the invention and also method of treatment of diseases such as diabetes insipidus, nocturnal enuresis, nocturia and urinary incontinence in a mammal in need of such treatment.
priorityDate 2006-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0013663-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003091623-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57201485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051933

Total number of triples: 29.